Showing results (121-130 of 141) with videos related to
Sort By:
Pageof 15
Future Medicinal Chemistry|May 21, 2013
Structure-activity relationship and in vitro pharmacological evaluation of imidazo[1,2-a]pyridine-based inhibitors of 5-LOEstel la Buscató, Joanna M Wisniewska, Carmen B Rödl, et al.The Journal of Pharmacology and Experimental Therapeutics|November 26, 2009
The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenaseAndreas Koeberle, Antonietta Rossi, Heiko Zettl, et al.Biochemical Pharmacology|July 30, 2022
Compilation and evaluation of a fatty acid mimetics screening libraryJohanna H M Ehrler, Steffen Brunst, Amelie Tjaden, et al.Nature Communications|July 4, 2019
Molecular tuning of farnesoid X receptor partial agonismDaniel Merk, Sridhar Sreeramulu, Denis Kudlinzki, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 6, 2011
Structural properties of so-called NSAID-phospholipid-complexesJan Hüsch, Bercem Dutagaci, Clemens Glaubitz, et al.European Journal of Pharmacology|March 10, 2015
Identification and characterisation of a prototype for a new class of competitive PPARγ antagonistsTilo Knape, Daniel Flesch, Laura Kuchler, et al.Journal of Personalized Medicine|January 21, 2022
Evidence-Based Decision Support for a Structured Care Program on Polypharmacy in Multimorbidity: A Guideline Upgrade Based on a Realist SynthesisTruc Sophia Dinh, Maria-Sophie Brueckle, Ana Isabel González-González, et al.Journal of Medicinal Chemistry|November 1, 2013
Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivoThomas Hanke, Friederike Dehm, Stefanie Liening, et al.Journal of Medicinal Chemistry|December 21, 2023
Synthesis of Pyrazole-Based Macrocycles Leads to a Highly Selective Inhibitor for MST3Jennifer Alisa Amrhein, Lena Marie Berger, Dimitrios-Ilias Balourdas, et al.Journal of Medicinal Chemistry|April 9, 2020
A Selective Modulator of Peroxisome Proliferator-Activated Receptor γ with an Unprecedented Binding ModeThomas Hanke, Sun-Yee Cheung, Whitney Kilu, et al.Pageof 15